| Brian Baker, | |
|
2500 Metrohealth Dr, Cleveland, OH 44109-1900 | |
| (216) 778-7800 | |
| Not Available |
| Full Name | Brian Baker |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 7 Years |
| Location | 2500 Metrohealth Dr, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902466626 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 67.000342 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Metrohealth System | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Metrohealth System | 8628982949 | 1026 |
News Archive
Moody's gave American not-for-profit health care sector a negative outlook because of uncertainly surrounding funding for federal health programs and gridlock surrounding the health law. But the S & P notes that revenue for Medicare and commercial insurers grew over the year that ended in June.
Scientists at The Scripps Research Institute have engineered a bacterium whose genetic material includes an added pair of DNA "letters," or bases, not found in nature. The cells of this unique bacterium can replicate the unnatural DNA bases more or less normally, for as long as the molecular building blocks are supplied.
UCLA scientists and colleagues studying the effects of cognitive behavioral therapy (CBT) discovered an abnormality in the brains of people with obsessive compulsive disorder (OCD) that may also help to predict who is most likely to respond to CBT.
On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.
› Verified 7 days ago
| Entity Name | The Metrohealth System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053353896 PECOS PAC ID: 8628982949 Enrollment ID: O20031119000355 |
News Archive
Moody's gave American not-for-profit health care sector a negative outlook because of uncertainly surrounding funding for federal health programs and gridlock surrounding the health law. But the S & P notes that revenue for Medicare and commercial insurers grew over the year that ended in June.
Scientists at The Scripps Research Institute have engineered a bacterium whose genetic material includes an added pair of DNA "letters," or bases, not found in nature. The cells of this unique bacterium can replicate the unnatural DNA bases more or less normally, for as long as the molecular building blocks are supplied.
UCLA scientists and colleagues studying the effects of cognitive behavioral therapy (CBT) discovered an abnormality in the brains of people with obsessive compulsive disorder (OCD) that may also help to predict who is most likely to respond to CBT.
On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Baker, 2500 Metrohealth Dr, Cleveland, OH 44109-1900 Ph: (216) 778-7800 | Brian Baker, 2500 Metrohealth Dr, Cleveland, OH 44109-1900 Ph: (216) 778-7800 |
News Archive
Moody's gave American not-for-profit health care sector a negative outlook because of uncertainly surrounding funding for federal health programs and gridlock surrounding the health law. But the S & P notes that revenue for Medicare and commercial insurers grew over the year that ended in June.
Scientists at The Scripps Research Institute have engineered a bacterium whose genetic material includes an added pair of DNA "letters," or bases, not found in nature. The cells of this unique bacterium can replicate the unnatural DNA bases more or less normally, for as long as the molecular building blocks are supplied.
UCLA scientists and colleagues studying the effects of cognitive behavioral therapy (CBT) discovered an abnormality in the brains of people with obsessive compulsive disorder (OCD) that may also help to predict who is most likely to respond to CBT.
On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.
› Verified 7 days ago
Shannon Kelly, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Olivia Kehoe, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-1000 | |
Brian Michael Wheatley, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Nicole M Moses, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Michael Marcotte, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Thomas Bruno, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-7330 | |
Gregory G Kychun, AA Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-7330 |